Assessing fatty acid biostatus: Red blood cells or plasma?

William S. Harris

doi:10.1002/lite.201300290

Assessing fatty acid biostatus: Red blood cells or plasma?

William S. Harris

Academic Affairs

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Omega-3 fatty acid (n-3 FA) biostatus can be estimated using red blood cell (RBC) membranes or plasma. The sample type that exhibits the lower within-person variability and is less affected by an acute dose of n-3 FA is preferred in clinical practice. The experiments described here indicate that RBC-based metrics are superior to plasma-based for use in patient care.

Original language	English (US)
Pages (from-to)	179-181
Number of pages	3
Journal	Lipid Technology
Volume	25
Issue number	8
DOIs	https://doi.org/10.1002/lite.201300290
State	Published - Aug 1 2013

ASJC Scopus subject areas

Control and Systems Engineering
Food Science
Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1002/lite.201300290

Cite this

@article{691cd66fbee9428a8d969eafb098ae36,

title = "Assessing fatty acid biostatus: Red blood cells or plasma?",

abstract = "Omega-3 fatty acid (n-3 FA) biostatus can be estimated using red blood cell (RBC) membranes or plasma. The sample type that exhibits the lower within-person variability and is less affected by an acute dose of n-3 FA is preferred in clinical practice. The experiments described here indicate that RBC-based metrics are superior to plasma-based for use in patient care.",

author = "Harris, {William S.}",

year = "2013",

month = aug,

day = "1",

doi = "10.1002/lite.201300290",

language = "English (US)",

volume = "25",

pages = "179--181",

journal = "Lipid Technology",

issn = "0956-666X",

publisher = "Wiley-VCH Verlag",

number = "8",

}

TY - JOUR

T1 - Assessing fatty acid biostatus

T2 - Red blood cells or plasma?

AU - Harris, William S.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Omega-3 fatty acid (n-3 FA) biostatus can be estimated using red blood cell (RBC) membranes or plasma. The sample type that exhibits the lower within-person variability and is less affected by an acute dose of n-3 FA is preferred in clinical practice. The experiments described here indicate that RBC-based metrics are superior to plasma-based for use in patient care.

AB - Omega-3 fatty acid (n-3 FA) biostatus can be estimated using red blood cell (RBC) membranes or plasma. The sample type that exhibits the lower within-person variability and is less affected by an acute dose of n-3 FA is preferred in clinical practice. The experiments described here indicate that RBC-based metrics are superior to plasma-based for use in patient care.

UR - http://www.scopus.com/inward/record.url?scp=84881289607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881289607&partnerID=8YFLogxK

U2 - 10.1002/lite.201300290

DO - 10.1002/lite.201300290

M3 - Article

AN - SCOPUS:84881289607

SN - 0956-666X

VL - 25

SP - 179

EP - 181

JO - Lipid Technology

JF - Lipid Technology

IS - 8

ER -

Assessing fatty acid biostatus: Red blood cells or plasma?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this